While the former was primarily managed with insulin or metformin to control glucose levels, the latter was often treated with lifestyle interventions or less effective pharmacotherapy
Some reported or potential side effects include nausea, facial flushing, decreased appetite, headache, fatigue or drowsiness, yawning/stretching, injection-site irritation, and changes in arousal or spontaneous erections
Known for its calming effects, it can help reduce anxiety and promote a state of relaxation, making it easier to fall asleep
10.1016/j.ejpb.2008.06.008 Eur
Abstract Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome and is prevalent in more than 50% of patients with type II diabetes
It is also the pathway that drives IGF-1 LR3's insulin-like glucose-lowering effect the same mechanism that creates hypoglycemia risk